Characterization of [125I]‐SB‐258585 binding to human recombinant and native 5‐HT6 receptors in rat, pig and human brain tissue
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
SB‐258585 (4‐Iodo‐N‐[4‐methoxy‐3‐(4‐methyl‐piperazin‐1‐yl)‐phenyl]‐benzenesulphonamide) is a high affinity ligand at 5‐HT 6 receptors. It displays over 100 fold selectivity for the 5‐HT 6 receptor over all other 5‐HT receptors tested so far. SB‐258585 has been radiolabelled, to high specific activity, for its characterization as a 5‐HT 6 receptor selective radioligand. [125 I]‐SB‐258585 bound, with high affinity, to a single population of receptors in a cell line expressing human recombinant 5‐HT 6 receptors. Kinetic and saturation binding experiments gave pK D values of 9.01±0.09 and 9.09±0.02, respectively. In membranes derived from rat or pig striatum and human caudate putamen, [125 I]‐SB‐258585 labelled a single site with high levels (>60%) of specific binding. Saturation analysis revealed p KD values of 8.56±0.07 for rat, 8.60±0.10 for pig and 8.90±0.02 for human. B max values for the tissues ranged from 173±23 and 181±25 fmol mg−1 protein in rat and pig striatum, respectively, to 215±41 fmol mg−1 protein in human caudate putamen. The p Ki rank order of potency for a number of compounds, determined in competition binding assays with [125 I]‐SB‐258585, at human caudate putamen membranes was: SB‐271046>SB‐258585>SB‐214111>methiothepin>clozapine>5‐Me‐OT>5‐HT>Ro 04‐6790>mianserin>ritanserin=amitriptyline>5‐CT>mesulergine. Similar profiles were obtained from pig and rat striatal membranes and recombinant 5‐HT 6 receptors; data from the latter correlated well with [3 H]‐LSD binding. Thus, [125 I]‐SB‐258585 is a high affinity, selective radioligand which can be used to label both recombinant and native 5‐HT 6 receptors and will facilitate further characterization of this receptor subtype in animal and human tissues. British Journal of Pharmacology (2000) 130, 1597–1605; doi:10.1038/sj.bjp.0703458
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Cited by
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
Molecular biology of 5-HT receptors
Hannon, J., & Hoyer, D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.020 · Cited by 815
Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
W. Pike, V. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160418114826 · Cited by 195
A serotonergic axon-cilium synapse drives nuclear signaling to alter chromatin accessibility
Sheu, S.-H., Upadhyayula, S., Dupuy, V., Pang, S., Deng, F., Wan, J., Walpita, D., Pasolli, H. A., Houser, J., Sanchez-Martinez, S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.07.026 · Cited by 162
“Adding the 5-HTR6 blocker SB258585 (100 nM, Hirst et al., 2000) or a G a q/11 inhibitor YM-254890 (1 m M; Nishimura et al., 2010; Takasaki et al., 2004) 5 min before 10-nM 5HT application largely abolished this effect (Figure 5H).”
Chemical Neuroanatomy of 5-HT Receptor Subtypes in the Mammalian Brain
Mengod, G., Vilaró, M. T., Cortés, R., López-Giménez, J. F., Raurich, A., & Palacios, J. M. (2006) · The Receptors · doi:10.1007/978-1-59745-080-5_10 · Cited by 33
Metadata
- Authors
- Hirst, W. D., Minton, J. A. L., Bromidge, S. M., Moss, S. F., Latter, A. J., Riley, G., Routledge, C., Middlemiss, D. N., & Price, G. W.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 130
- Issue
- 7
- Pages
- 1597-1605
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2086275553
- Cited by
- 120
- References
- 1
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.